Orca Bio
Ling Wong is the Founder, General Partner, and CEO of Highbury Group since 2013. In addition to this role, Ling Wong serves as an investor for several companies, including Devoted Health, BioAge Labs, Stripe, Guardant Health, Slack, Orca Bio, Solugen, Notion, and Modern Animal, all of which have been ongoing since their respective start dates between 2014 and 2019. Ling Wong holds a Ph.D. in Applied Sciences, Bioengineering, Entrepreneurship, and Global Health, as well as a Master of Science in Engineering Sciences from Harvard University. Furthermore, Ling Wong earned a Bachelor of Science in Chemical Engineering and a Bachelor of Science in Biology from the Massachusetts Institute of Technology.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
Orca Bio
3 followers
Orca Bio is a clinical-stage biotechnology company developing a pipeline of high precision allogeneic cell therapy products that are designed to safely replace patients’ diseased blood and immune system with a healthy one. Their manufacturing platform sorts donor blood with single-cell precision and a high level of purity and speed, enabling them to create proprietary, optimal therapeutic mixtures of immune and stem cells that have the potential to transform allogeneic cell therapy. Their talented team is driven by a passion for science and compassion for patients.